bf/NASDAQ:LUMO_icon.png

NASDAQ:LUMO

Lumos Pharma, Inc.

  • Stock

USD

Last Close

3.92

25/09 14:34

Market Cap

14.37M

Beta: 0.65

Volume Today

1.09K

Avg: 11.78K

PE Ratio

−0.78

PFCF: −0.81

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
average inventory
-369K
-
1.86M
605.28%
-829.50K
144.49%
-2.69M
224.77%
average payables
2.22M
-
2.94M
32.40%
7.42M
152.06%
17.65M
138.00%
16.07M
8.97%
4.91M
69.47%
515K
89.50%
359.50K
30.19%
428K
19.05%
443.50K
3.62%
582.50K
31.34%
average receivables
1.20M
-
8.63M
620.71%
10.50M
21.62%
5.68M
45.87%
8.25M
45.27%
5.67M
31.36%
811K
85.68%
13.54M
1,570.04%
13.20M
2.57%
175.50K
98.67%
216.50K
23.36%
book value per share
20.77
-
65.88
217.20%
61.64
6.44%
40.21
34.77%
43.57
8.37%
27.86
36.05%
60.56
117.36%
17.20
71.60%
10.68
37.93%
7.12
33.35%
3.35
52.89%
capex per share
-0.49
-
-0.55
11.36%
-1.26
128.85%
-0.70
44.54%
-0.01
98.23%
-0.00
86.30%
-0.00
-
-0.00
18.68%
-0.00
30.33%
capex to depreciation
-1.56
-
-1.55
0.38%
-2.51
61.93%
-1.08
57.05%
-0.03
97.16%
-0.01
80.00%
-0.05
-
-0.15
187.68%
-0.43
190.00%
capex to operating cash flow
0.05
-
-0.02
129.03%
0.17
1,164.10%
0.03
79.47%
0.00
97.38%
0.00
79.28%
0.00
-
0.00
22.43%
0.00
22.05%
capex to revenue
-1.27
-
-0.01
99.19%
-0.11
979.00%
-0.64
476.28%
-0.11
82.69%
-0.01
94.74%
-0.18
-
-0.13
26.96%
-0.01
89.43%
cash per share
21.91
-
65.56
199.19%
62.27
5.02%
40.84
34.42%
45.63
11.74%
29.22
35.97%
69.53
137.96%
14.56
79.06%
11.38
21.87%
8.04
29.29%
4.43
44.94%
days of inventory on hand
-204.92
-
60.78
129.66%
days payables outstanding
-132.55
-
-140.12
5.71%
-17.98
-
7.38K
-
days sales outstanding
553.34
-
34.32
93.80%
54.41
58.54%
618.51
1,036.72%
9.86K
1,493.64%
241.52
97.55%
321.32
33.04%
57.06K
17,658.25%
203.13
99.64%
53.44
73.69%
37.37
30.07%
debt to assets
0.10
-
0.00
95.68%
0.00
2.77%
0.00
31.14%
0.00
49.31%
0.00
47.04%
0.01
1,493.51%
0.00
80.47%
0.01
124.60%
0.00
41.96%
0.15
4,696.23%
debt to equity
0.12
-
0.01
95.83%
0.00
7.09%
0.00
16.74%
0.00
55.22%
0.00
49.49%
0.02
1,619.43%
0.00
82.38%
0.01
128.76%
0.00
37.53%
0.23
5,783.42%
dividend yield
0.02
-
0.04
84.58%
0.01
78.66%
0.05
-
0.01
75.36%
earnings yield
-0.50
-
0.84
265.84%
-0.35
141.76%
-2.57
636.37%
-2.55
0.85%
-8.53
234.52%
-13.05
52.90%
-0.02
99.82%
-0.53
2,151.79%
-1.03
95.03%
-1.31
27.88%
enterprise value
7.55M
-
-66.59M
981.53%
-79.67M
19.64%
-98.10M
23.14%
-130.39M
32.91%
-114.35M
12.30%
-86.03M
24.77%
143.68M
267.01%
-36.49M
125.40%
-25.54M
30.00%
-2.59M
89.86%
enterprise value over ebitda
-0.24
-
-0.57
133.49%
2.37
518.62%
1.08
54.41%
1.79
65.51%
1.89
5.63%
2.00
6.05%
-5.46
372.57%
1.16
121.31%
0.80
31.52%
0.07
91.11%
ev to operating cash flow
-0.29
-
-0.61
108.67%
3.31
641.74%
1.49
55.02%
2.70
81.54%
3.01
11.61%
2.85
5.51%
-6.25
319.38%
1.23
119.70%
0.96
22.05%
0.08
91.31%
ev to sales
6.91
-
-0.40
105.81%
-2.20
449.32%
-27.82
1,162.27%
-334.33
1,101.62%
-94.82
71.64%
-91.91
3.07%
855.24
1,030.50%
-158.67
118.55%
-16.77
89.43%
-1.26
92.47%
free cash flow per share
-9.69
-
34.71
458.33%
-8.84
125.47%
-21.18
139.54%
-13.89
34.40%
-9.18
33.91%
-23.19
152.58%
-3.40
85.35%
-3.56
4.81%
-3.18
10.64%
-3.82
19.98%
free cash flow yield
-0.44
-
0.87
298.41%
-0.24
127.82%
-2.06
747.96%
-1.71
16.85%
-6.04
252.65%
-9.17
51.75%
-0.10
98.96%
-0.51
440.10%
-0.88
71.53%
-1.20
36.21%
graham net net
18.00
-
58.86
227.01%
55.53
5.66%
28.17
49.28%
39.52
40.32%
25.54
35.38%
56.25
120.24%
15.63
72.22%
10.03
35.83%
6.55
34.71%
2.81
57.05%
graham number
72.03
-
222.01
208.22%
132.78
40.19%
154.68
16.49%
142.41
7.93%
90.17
36.68%
212.08
135.20%
17.98
91.52%
29.61
64.70%
24.37
17.71%
17.75
27.15%
income quality
0.83
-
1.06
28.06%
0.60
43.75%
0.77
29.83%
0.67
13.35%
0.71
5.49%
0.70
0.74%
4.06
477.93%
0.97
76.01%
0.86
12.03%
0.91
6.60%
intangibles to total assets
0
-
0
0
0
0
0
0
0
0
0
0
interest coverage
-943.67
-
4.52K
579.20%
-320.02
107.08%
-4.13K
1,189.10%
-612.45
85.15%
-1.20K
96.06%
-902.68
24.82%
-36.66
-
interest debt per share
2.58
-
0.35
86.51%
0.33
5.69%
0.17
49.07%
0.11
33.02%
0.04
66.33%
0.98
2,493.24%
0.05
95.19%
0.07
42.00%
0.13
97.81%
0.77
483.41%
inventory turnover
-1.78
-
6.01
437.17%
invested capital
0.12
-
0.01
95.83%
0.00
7.09%
0.00
16.74%
0.00
55.22%
0.00
49.49%
0.02
1,619.43%
0.00
82.38%
0.01
128.76%
0.00
37.53%
0.23
5,783.42%
market cap
61.81M
-
122.95M
98.92%
115.58M
5.99%
33.10M
71.36%
28.21M
14.78%
6.28M
77.73%
3.30M
47.54%
242.04M
7,245.57%
57.76M
76.14%
30.23M
47.66%
25.90M
14.32%
net current asset value
51.74M
-
196.18M
279.16%
185.37M
5.51%
122.63M
33.85%
146.33M
19.32%
111.28M
23.95%
76.51M
31.24%
115.99M
51.60%
88.34M
23.84%
59.30M
32.87%
26.70M
54.97%
net debt to ebitda
1.74
-
-1.61
192.53%
5.81
460.44%
1.45
75.12%
2.18
50.53%
1.99
8.39%
2.08
4.38%
3.74
79.71%
3.01
19.60%
1.74
42.10%
0.78
55.24%
net income per share
-11.10
-
33.25
399.51%
-12.71
138.23%
-26.45
108.02%
-20.69
21.78%
-12.97
37.30%
-33.01
154.50%
-0.84
97.47%
-3.65
336.99%
-3.71
1.60%
-4.18
12.64%
operating cash flow per share
-9.19
-
35.26
483.55%
-7.58
121.51%
-20.48
170.08%
-13.88
32.23%
-9.18
33.86%
-23.19
152.63%
-3.39
85.37%
-3.56
4.84%
-3.18
10.62%
-3.82
20.08%
payables turnover
-2.75
-
-2.60
5.40%
-20.30
-
0.05
-
receivables turnover
0.66
-
10.64
1,512.29%
6.71
36.93%
0.59
91.20%
0.04
93.73%
1.51
3,981.23%
1.14
24.84%
0.01
99.44%
1.80
27,991.15%
6.83
280.08%
9.77
43.01%
research and ddevelopement to revenue
20.78
-
0.22
98.97%
1.98
818.71%
26.46
1,239.18%
179.14
577.02%
37.89
78.85%
23.72
37.39%
54.80
130.99%
70.63
28.90%
11.72
83.40%
10.77
8.12%
return on tangible assets
-0.44
-
0.43
197.77%
-0.18
142.77%
-0.49
163.73%
-0.40
18.29%
-0.41
2.79%
-0.44
8.51%
-0.04
90.12%
-0.30
591.20%
-0.43
41.64%
-0.84
94.91%
revenue per share
0.39
-
53.65
13,684.77%
11.38
78.79%
1.10
90.38%
0.11
89.76%
0.29
160.28%
0.72
146.26%
0.02
96.55%
0.03
11.34%
0.18
559.07%
0.25
38.45%
roe
-0.53
-
0.50
194.42%
-0.21
140.86%
-0.66
218.88%
-0.47
27.82%
-0.47
1.95%
-0.55
17.09%
-0.05
91.09%
-0.34
604.00%
-0.52
52.43%
-1.25
139.10%
roic
-0.48
-
0.50
205.26%
-0.21
140.85%
-0.66
220.42%
-0.48
27.49%
-0.48
0.65%
-0.56
15.85%
-0.06
88.35%
-0.34
426.62%
-0.53
56.48%
-1.08
102.40%
sales general and administrative to revenue
8.71
-
0.12
98.66%
0.85
629.04%
9.42
1,009.78%
81.35
763.29%
24.23
70.22%
25.50
5.24%
102.77
303.06%
66.66
35.14%
10.31
84.53%
8.08
21.66%
shareholders equity per share
20.77
-
65.88
217.20%
61.64
6.44%
40.21
34.77%
43.57
8.37%
27.86
36.05%
60.56
117.36%
17.20
71.60%
10.68
37.93%
7.12
33.35%
3.35
52.89%
stock based compensation to revenue
3.99
-
0.05
98.70%
0.44
749.74%
4.74
974.37%
47.46
901.56%
14.20
70.09%
7.18
49.41%
6.39
10.98%
12.52
95.80%
1.52
87.83%
1.13
25.68%
tangible asset value
58.33M
-
203.78M
249.37%
195.77M
3.93%
129.47M
33.87%
151.56M
17.06%
115.14M
24.03%
78.88M
31.50%
116.57M
47.79%
88.98M
23.67%
59.58M
33.03%
27.30M
54.17%
tangible book value per share
20.77
-
65.88
217.20%
61.64
6.44%
40.21
34.77%
43.57
8.37%
27.86
36.05%
60.56
117.36%
17.20
71.60%
10.68
37.93%
7.12
33.35%
3.35
52.89%
working capital
60.09M
-
205.36M
241.73%
193.30M
5.87%
130.01M
32.74%
153.44M
18.02%
118.22M
22.95%
82.59M
30.14%
121.99M
47.70%
94.55M
22.49%
65.30M
30.93%
33.01M
49.46%

All numbers in USD (except ratios and percentages)